• Return to search results
• Start new search

Investigator(s):
Katherine E. Warren, M.D. Principal Investigator Phone: 301-496-4256
Referral Contact(s):
Robyn Bent, R.N. Research Nurse Phone: 301-496-8009 rbent@mail.nih.gov	Pediatric Oncology  Phone: 1-877-624-4878 (Toll free)

---

Primary Eligibility:

• Ages 1 through 21
• Brain tumor or residual abnormality after therapy for brain tumors
• Able to undergo imaging studies
• No uncontrolled diabetes
• No metallic implants
• No history of severe reaction to contrast agents

---

Study Outline:

• Patients referred for this trial will have both ¹H-MRSI and¹⁸F-FDG PET imaging performed within 2 weeks of each other at NCI

---

Additional Information:

• This trial will be conducted at the NIH Clinical Center in Bethesda, MD. It is open to patients who meet the eligibility requirements, regardless of where they live in the United States.
• There is no charge for medical care received at NIH Clinical Center.
• FAQs about this study - provides information for patients about the trial such as frequency and duration of visits, costs, how to enroll, treatment plan.
• PDQ (Physicians Data Query) - provides additional details about this study for health care providers.

Reviewed: 6/8/09
Updated: 6/22/09